Fiserv Inc. (FISV)

Sector:Information Technology
Super Investor Stats:
Ownership count:9
Ownership rank:52
% of all portfolios:0.13%
Hold Price * :$49.05
History Portfolio Manager Activity ▲ Share change % change to portfolio
Q2  2026
≡ Vulcan Value Partners Reduce 18.33% 200,694 0.30
≡ Christopher Davis - Davis Advisors Reduce 8.33% 49,046 0.01
≡ Hillman Capital Management Reduce 2.81% 2,272 0.08
≡ Samantha McLemore - Patient Capital Management Reduce 1.50% 14,557 0.02
≡ Dodge & Cox Funds Reduce 0.13% 66,004 0.00
≡ Mason Hawkins - Southeastern Asset Management Sell 100.00% 3,990 0.01
Q1  2026
≡ Vulcan Value Partners Reduce 23.86% 342,984 0.51
≡ Seth Klarman - Baupost Group Sell 100.00% 2,200,000 2.80
Q4  2025
≡ Mairs & Power Funds Reduce 6.10% 106,681 0.07
≡ Torray Funds Sell 100.00% 45,561 0.82
≡ David Katz - Matrix Asset Advisors Sell 100.00% 78,306 0.94
≡ Norbert Lou - Punch Card Management Sell 100.00% 37,000 1.48
≡ David Tepper - Appaloosa Management Sell 100.00% 925,000 1.62
≡ Francois Rochon - Giverny Capital Sell 100.00% 651,257 2.85
Q3  2025
≡ Torray Funds Reduce 1.90% 882 0.02
≡ Leon Cooperman Sell 100.00% 390,000 2.36
Q2  2025
≡ Torray Funds Reduce 61.01% 72,687 1.82
≡ Bill Nygren - Oakmark Funds Reduce 5.66% 319,849 0.09
≡ Dodge & Cox Funds Reduce 2.85% 870,955 0.08
≡ John Armitage - Egerton Capital Sell 100.00% 2,381,496 6.07
Q1  2025
≡ Bill Nygren - Oakmark Funds Reduce 37.58% 3,402,551 1.26
≡ Mairs & Power Funds Reduce 8.22% 153,852 0.35
≡ Torray Funds Reduce 5.06% 6,355 0.21
≡ Dodge & Cox Funds Reduce 4.98% 1,601,904 0.20
≡ Francois Rochon - Giverny Capital Reduce 0.10% 621 0.01
≡ Samantha McLemore - Patient Capital Management Sell 100.00% 10,042 0.10
≡ Vulcan Value Partners Sell 100.00% 146,008 0.50
≡ David Katz - Matrix Asset Advisors Sell 100.00% 31,264 0.70
Q4  2024
≡ Samantha McLemore - Patient Capital Management Reduce 92.44% 122,828 1.22
≡ Vulcan Value Partners Reduce 67.13% 298,224 1.02
≡ Bill Nygren - Oakmark Funds Reduce 33.87% 4,636,188 1.58
≡ Leon Cooperman Reduce 20.83% 100,000 0.78
≡ Torray Funds Reduce 17.14% 25,965 0.77
≡ David Katz - Matrix Asset Advisors Reduce 13.09% 4,707 0.11
≡ John Armitage - Egerton Capital Reduce 9.85% 253,886 0.60
≡ Dodge & Cox Funds Reduce 1.62% 531,372 0.06
≡ Mairs & Power Funds Reduce 1.17% 22,227 0.04
≡ Sarah Ketterer - Causeway Capital Management Sell 100.00% 292,231 1.33
Q3  2024
≡ Sarah Ketterer - Causeway Capital Management Reduce 32.19% 138,723 0.63
≡ Samantha McLemore - Patient Capital Management Reduce 30.68% 58,820 0.52
≡ Vulcan Value Partners Reduce 26.00% 156,086 0.47
≡ Bill Nygren - Oakmark Funds Reduce 7.45% 1,102,003 0.33
≡ John Armitage - Egerton Capital Reduce 5.78% 158,255 0.29
≡ Dodge & Cox Funds Reduce 4.79% 1,647,611 0.17
≡ David Katz - Matrix Asset Advisors Reduce 3.06% 1,137 0.02
≡ John Rogers - Ariel Investments Reduce 2.18% 101 0.00
≡ Mason Hawkins - Southeastern Asset Management Sell 100.00% 211,917 1.38
≡ ValueAct Capital Sell 100.00% 1,103,759 4.63
Q2  2024
≡ ValueAct Capital Reduce 69.81% 2,551,882 10.70
≡ John Armitage - Egerton Capital Reduce 19.32% 655,536 0.99
≡ Samantha McLemore - Patient Capital Management Reduce 17.89% 41,755 0.33
≡ Vulcan Value Partners Reduce 7.33% 47,462 0.11
≡ Mason Hawkins - Southeastern Asset Management Reduce 6.57% 14,893 0.10
≡ David Katz - Matrix Asset Advisors Reduce 1.83% 690 0.01
≡ Mairs & Power Funds Reduce 0.91% 17,414 0.03
≡ Dodge & Cox Funds Reduce 0.69% 238,631 0.02
≡ Torray Funds Reduce 0.07% 110 0.00
Q1  2024
≡ David Katz - Matrix Asset Advisors Reduce 49.97% 37,751 0.72
≡ Sarah Ketterer - Causeway Capital Management Reduce 21.38% 115,450 0.50
≡ ValueAct Capital Reduce 12.73% 533,200 1.88
≡ Samantha McLemore - Patient Capital Management Reduce 9.05% 23,234 0.18
≡ John Armitage - Egerton Capital Reduce 1.62% 56,007 0.09
≡ Torray Funds Reduce 0.61% 927 0.02
Q4  2023
≡ ValueAct Capital Reduce 44.51% 3,360,000 8.94
≡ Sarah Ketterer - Causeway Capital Management Reduce 18.57% 123,180 0.44
≡ David Katz - Matrix Asset Advisors Reduce 7.24% 5,894 0.10
≡ Samantha McLemore - Patient Capital Management Reduce 5.15% 13,947 0.10
≡ John Armitage - Egerton Capital Reduce 2.57% 91,085 0.13
≡ Lee Ainslie - Maverick Capital Sell 100.00% 5,087 0.01
Q3  2023
≡ Lee Ainslie - Maverick Capital Reduce 38.38% 3,169 0.01
≡ ValueAct Capital Reduce 35.19% 4,098,935 10.40
≡ Samantha McLemore - Patient Capital Management Reduce 6.55% 18,983 0.13
≡ Torray Funds Reduce 1.40% 2,158 0.04
≡ David Katz - Matrix Asset Advisors Reduce 0.92% 760 0.01
Q2  2023
≡ Sarah Ketterer - Causeway Capital Management Reduce 4.93% 33,825 0.12
≡ John Armitage - Egerton Capital Reduce 3.38% 118,355 0.15
≡ David Katz - Matrix Asset Advisors Reduce 1.93% 1,616 0.03
≡ Torray Funds Reduce 0.56% 860 0.02
≡ Seth Klarman - Baupost Group Sell 100.00% 533,382 1.08
≡ Bill Miller - Miller Value Partners Sell 100.00% 287,648 2.03
Q1  2023
≡ Seth Klarman - Baupost Group Reduce 73.36% 1,469,009 2.97
≡ Bill Miller - Miller Value Partners Reduce 24.80% 94,842 0.67
≡ ValueAct Capital Reduce 20.48% 3,000,000 5.52
≡ Samantha McLemore - Patient Capital Management Reduce 18.93% 12,475 0.63
≡ David Katz - Matrix Asset Advisors Reduce 5.24% 4,632 0.08
≡ Torray Funds Reduce 0.14% 215 0.00
Q4  2022
≡ Seth Klarman - Baupost Group Reduce 43.31% 1,530,000 2.63
≡ Bill Miller - Miller Value Partners Reduce 20.94% 101,302 0.66
≡ Samantha McLemore - Patient Capital Management Reduce 11.78% 8,800 0.44
≡ David Katz - Matrix Asset Advisors Reduce 2.64% 2,402 0.04
Q3  2022
≡ Torray Funds Reduce 71.98% 143,557 2.67
≡ Leon Cooperman Reduce 48.26% 415,000 2.72
≡ Bill Miller - Miller Value Partners Reduce 17.84% 105,021 0.60
≡ Samantha McLemore - Patient Capital Management Reduce 1.97% 1,500 0.07
Q2  2022
≡ David Katz - Matrix Asset Advisors Reduce 28.32% 34,815 0.47
≡ Leon Cooperman Reduce 16.55% 170,600 1.04
≡ Seth Klarman - Baupost Group Reduce 11.43% 456,000 0.62
≡ Bill Miller - Miller Value Partners Reduce 6.43% 40,468 0.20
≡ Torray Funds Reduce 5.86% 12,407 0.21
Q4  2021
≡ Torray Funds Reduce 0.36% 734 0.01

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.